Table 2.
Population | Incidence of Parkinson’s disease in patients with osteoarthritisa | Incidence of Parkinson’s disease in patients without osteoarthritisa | Unadjusted hazard ratio (95% confidence interval) | P-value | Adjusted hazard ratio (95% confidence interval)b | P-value |
---|---|---|---|---|---|---|
Overall | 124.1 | 67.1 | 1.85 (1.66–2.06) | <0.001 | 1.82 (1.63–2.02) | <0.001 |
By sex | ||||||
Female | 101.1 | 52.6 | 1.92 (1.65–2.24) | <0.001 | 1.88 (1.61–2.19) | <0.001 |
Male | 161.8 | 90.8 | 1.78 (1.53–2.07) | <0.001 | 1.75 (1.51–2.04) | <0.001 |
By age (in years) | ||||||
Age ≤ 50 | 14.7 | 4.2 | 3.48 (1.15–10.58) | 0.028 | 3.22 (1.06–9.38) | 0.040 |
Age 51–60 | 39.1 | 17.9 | 2.18 (1.47–3.24) | <0.001 | 2.12 (1.43–3.14) | <0.001 |
Age 61–70 | 116.3 | 54.1 | 2.15 (1.72–2.68) | <0.001 | 2.14 (1.72–2.67) | <0.001 |
Age 71–80 | 243.7 | 136.8 | 1.78 (1.52–2.09) | <0.001 | 1.79 (1.53–2.09) | <0.001 |
Age > 80 | 218.3 | 139.8 | 1.56 (1.24–1.96) | <0.001 | 1.59 (1.27–1.99) | <0.001 |
Number of patients diagnosed with Parkinson’s disease per 100,000 people.
Adjusted Cox regression models included hypertension, diabetes mellitus, thyroid diseases, dyslipidemia, coronary heart disease, gout, chronic obstructive pulmonary disease, stroke including transient ischemic attack, and intracranial injury.